体外杀菌活性的棘白菌素类药物对念珠菌属 metapsilosis 、 C. orthopsilosis 和 C. parapsilosis 通过时间杀死研究评估。
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.
机构信息
Unidad de Microbiología Experimental, Centro de Investigación, Hospital Universitario La Fe, Valencia. Spain.
出版信息
Antimicrob Agents Chemother. 2010 May;54(5):2194-7. doi: 10.1128/AAC.01538-09. Epub 2010 Feb 9.
Abstract
Anidulafungin, micafungin, and caspofungin in vitro activities against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis were evaluated by MICs and time-kill methods. All echinocandins showed lower MICs (mean MICs, 0.05 to 0.71 mg/liter) and the highest killing rates (-0.06 to -0.05 CFU/ml/h) for C. metapsilosis and C. orthopsilosis rather than for C. parapsilosis (mean MICs, 0.59 to 1.68 mg/liter). Micafungin and anidulafungin killing rates were greater than those determined for caspofungin. None of the echinocandins had fungicidal activity against C. parapsilosis.
摘要
对近平滑念珠菌、中间型念珠菌和副热带念珠菌进行 MIC 和时间杀伤方法评估，发现阿尼芬净、米卡芬净和卡泊芬净对近平滑念珠菌和中间型念珠菌的体外活性均较低（MIC 均值分别为 0.05 至 0.71 毫克/升），杀菌率最高（-0.06 至-0.05 CFU/ml/h），而对副热带念珠菌的活性则较低（MIC 均值分别为 0.59 至 1.68 毫克/升）。米卡芬净和阿尼芬净的杀菌率大于卡泊芬净。所有棘白菌素类药物对副热带念珠菌均无杀菌活性。
相似文献
1
In vitro fungicidal activities of echinocandins against Candida metapsilosis, C. orthopsilosis, and C. parapsilosis evaluated by time-kill studies.体外杀菌活性的棘白菌素类药物对念珠菌属 metapsilosis 、 C. orthopsilosis 和 C. parapsilosis 通过时间杀死研究评估。
Antimicrob Agents Chemother. 2010 May;54(5):2194-7. doi: 10.1128/AAC.01538-09. Epub 2010 Feb 9.
2
Killing kinetics of anidulafungin, caspofungin and micafungin against Candida parapsilosis species complex: Evaluation of the fungicidal activity.阿尼芬净、卡泊芬净和米卡芬净对近平滑念珠菌复合种的杀菌动力学：杀真菌活性评估
Rev Iberoam Micol. 2019 Jan-Mar;36(1):24-29. doi: 10.1016/j.riam.2018.12.001. Epub 2019 Mar 2.
3
In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.通过三种方法测定棘白菌素对克柔念珠菌的体外活性：最小抑菌浓度（MIC）和最小杀菌浓度测定以及时间杀菌研究。
Antimicrob Agents Chemother. 2009 Jul;53(7):3108-11. doi: 10.1128/AAC.00160-09. Epub 2009 Apr 20.
4
In vitro and in vivo effects of echinocandins against Candida parapsilosis sensu stricto, Candida orthopsilosis and Candida metapsilosis.棘白菌素类药物对近平滑念珠菌、近平滑假丝酵母和中间假丝酵母的体外和体内作用。
J Antimicrob Chemother. 2012 Sep;67(9):2195-202. doi: 10.1093/jac/dks180. Epub 2012 May 25.
5
In vitro fungicidal activities of anidulafungin, caspofungin, and micafungin against Candida glabrata, Candida bracarensis, and Candida nivariensis evaluated by time-kill studies.通过时间-杀菌研究评估阿尼芬净、卡泊芬净和米卡芬净对光滑念珠菌、布拉氏念珠菌和尼瓦念珠菌的体外杀菌活性。
Antimicrob Agents Chemother. 2015;59(6):3615-8. doi: 10.1128/AAC.04474-14. Epub 2015 Mar 23.
6
[Prevalence of Candida parapsilosis, C. orthopsilosis and C. metapsilosis in candidemia over a 5-year period at Nantes hospital and in vitro susceptibility to three echinocandins by E-test®].[南特医院5年期间念珠菌血症中近平滑念珠菌、正平滑念珠菌和副平滑念珠菌的患病率以及通过E-test®对三种棘白菌素的体外敏感性]
Pathol Biol (Paris). 2011 Feb;59(1):52-6. doi: 10.1016/j.patbio.2010.07.019. Epub 2010 Sep 15.
7
Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.用时间杀菌法检测棘白菌素类对葡萄牙念珠菌的体外杀菌活性。
J Antimicrob Chemother. 2013 Apr;68(4):864-8. doi: 10.1093/jac/dks489. Epub 2012 Dec 9.
8
Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.卡泊芬净对白色念珠菌和近平滑念珠菌分支的抗真菌后效应。
Diagn Microbiol Infect Dis. 2016 Oct;86(2):172-7. doi: 10.1016/j.diagmicrobio.2016.07.011. Epub 2016 Jul 12.
9
Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit.阿尼芬净、卡泊芬净和米卡芬净对从烧伤病房分离出的近平滑念珠菌菌株的体外活性差异。
Clin Microbiol Infect. 2009 Mar;15(3):274-9. doi: 10.1111/j.1469-0691.2008.02660.x. Epub 2009 Feb 5.
10
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.念珠菌属侵袭性分离株对阿尼芬净、卡泊芬净和米卡芬净的体外敏感性：六年全球监测
J Clin Microbiol. 2008 Jan;46(1):150-6. doi: 10.1128/JCM.01901-07. Epub 2007 Nov 21.
引用本文的文献
1
In Vitro Susceptibility Tests in the Context of Antifungal Resistance: Beyond Minimum Inhibitory Concentration in spp.抗真菌耐药背景下的体外药敏试验：超越某菌属的最低抑菌浓度
J Fungi (Basel). 2023 Dec 12;9(12):1188. doi: 10.3390/jof9121188.
2
Activity of Fenticonazole against and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.芬替康唑对单一或混合物种检测试验中分离的 和细菌性阴道病的活性。
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.02693-18. Print 2019 Jul.
3
Postantifungal effect of anidulafungin against Candida albicans, Candida dubliniensis, Candida africana, Candida parapsilosis, Candida metapsilosis and Candida orthopsilosis.阿尼芬净对白色念珠菌、都柏林念珠菌、非洲念珠菌、近平滑念珠菌、间平滑念珠菌和正平滑念珠菌的抗真菌后效应
Rev Esp Quimioter. 2019 Apr;32(2):183-188. Epub 2019 Mar 8.
4
Candida parapsilosis: from Genes to the Bedside.近平滑念珠菌：从基因到临床。
Clin Microbiol Rev. 2019 Feb 27;32(2). doi: 10.1128/CMR.00111-18. Print 2019 Mar 20.
5
Methodologies for and evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.抗真菌和抗生物膜剂以及表面涂层针对真菌生物膜的作用方法及疗效评估
Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638.
6
Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials.阿尼芬净治疗539例侵袭性念珠菌病患者的疗效：六项临床试验的患者水平汇总分析
J Antimicrob Chemother. 2017 Aug 1;72(8):2368-2377. doi: 10.1093/jac/dkx116.
7
Caspofungin-Non-Susceptible Isolated from Onychomycosis in Iran.从伊朗甲癣患者中分离出的对卡泊芬净不敏感的菌株
Iran J Public Health. 2017 Feb;46(2):235-241.
8
High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran.伊朗烧伤念珠菌血症患者中分离出的非白色念珠菌属的高回收率。
Jundishapur J Microbiol. 2015 Oct 24;8(10):e22929. doi: 10.5812/jjm.22929. eCollection 2015 Oct.
9
Dose escalation studies with caspofungin against Candida glabrata.卡泊芬净针对光滑念珠菌的剂量递增研究。
J Med Microbiol. 2015 Sep;64(9):998-1007. doi: 10.1099/jmm.0.000116. Epub 2015 Jun 30.
10
Postantifungal Effect of Micafungin against the Species Complexes of Candida albicans and Candida parapsilosis.米卡芬净对白色念珠菌和近平滑念珠菌复合菌的抗真菌后效应
PLoS One. 2015 Jul 13;10(7):e0132730. doi: 10.1371/journal.pone.0132730. eCollection 2015.
本文引用的文献
1
Identification of pathogenic yeast species by polymerase chain reaction amplification of the RPS0 gene intron fragment.通过聚合酶链反应扩增 RPS0 基因内含子片段鉴定致病性酵母种属。
J Appl Microbiol. 2010 Jun;108(6):1917-27. doi: 10.1111/j.1365-2672.2009.04595.x. Epub 2009 Oct 20.
2
In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.CLSI 肉汤微量稀释法检测七种系统作用抗真菌药物对大量全球罕见念珠菌的体外活性。
J Clin Microbiol. 2009 Oct;47(10):3170-7. doi: 10.1128/JCM.00942-09. Epub 2009 Aug 26.
3
Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital.一家三级护理医院中近平滑念珠菌、正平滑念珠菌和间平滑念珠菌的患病率、分布及抗真菌药敏谱
J Clin Microbiol. 2009 Aug;47(8):2392-7. doi: 10.1128/JCM.02379-08. Epub 2009 Jun 3.
4
In vitro activities of echinocandins against Candida krusei determined by three methods: MIC and minimal fungicidal concentration measurements and time-kill studies.通过三种方法测定棘白菌素对克柔念珠菌的体外活性：最小抑菌浓度（MIC）和最小杀菌浓度测定以及时间杀菌研究。
Antimicrob Agents Chemother. 2009 Jul;53(7):3108-11. doi: 10.1128/AAC.00160-09. Epub 2009 Apr 20.
5
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.念珠菌病管理临床实践指南：美国传染病学会2009年更新版
Clin Infect Dis. 2009 Mar 1;48(5):503-35. doi: 10.1086/596757.
6
Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis.卡泊芬净对近平滑念珠菌、正平滑念珠菌和间平滑念珠菌的杀菌活性比较。
J Antimicrob Chemother. 2008 Dec;62(6):1466-8. doi: 10.1093/jac/dkn403. Epub 2008 Sep 28.
7
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints.针对念珠菌属对卡泊芬净、阿尼芬净和米卡芬净的药敏试验，其最低抑菌浓度（MIC）与结果的相关性：分析及MIC解释性折点建议
J Clin Microbiol. 2008 Aug;46(8):2620-9. doi: 10.1128/JCM.00566-08. Epub 2008 Jun 25.
8
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis.新描述的近平滑念珠菌和季也蒙念珠菌与密切相关的副平滑念珠菌相比的地理分布及抗真菌药敏性
J Clin Microbiol. 2008 Aug;46(8):2659-64. doi: 10.1128/JCM.00803-08. Epub 2008 Jun 18.
9
A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.近平滑念珠菌、正平滑念珠菌和副平滑念珠菌中Fks1p天然存在的脯氨酸到丙氨酸的氨基酸变化导致棘白菌素敏感性降低。
Antimicrob Agents Chemother. 2008 Jul;52(7):2305-12. doi: 10.1128/AAC.00262-08. Epub 2008 Apr 28.
10
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.近平滑念珠菌和正平滑念珠菌的患病率及易感性概况：西班牙念珠菌血症人群监测结果
Antimicrob Agents Chemother. 2008 Apr;52(4):1506-9. doi: 10.1128/AAC.01595-07. Epub 2008 Feb 19.
Zotero 插件